Historique
Périodique
Hepatitis C virus seroprevalence rate among Saudis
(Taux de séroprévalence au virus de l'hépatite C parmi les Saoudiens)
Auteur(s) :
SHOBOKSHI O. A. ;
SEREBOUR F. E. ;
AL-DREES, A. Z. ;
MITWALLI A. H. ;
QAHTANI A. ;
SKAKNI L. I.
Année
2003
Page(s) :
S81-S86
Langue(s) :
Français
Refs biblio. :
44
Domaine :
Drogues illicites / Illicit drugs
Discipline :
MAL (Maladies infectieuses / Infectious diseases)
Thésaurus mots-clés
HEPATITE
;
INFECTION
;
PREVALENCE
;
EPIDEMIOLOGIE
Thésaurus géographique
ARABIE SAOUDITE
Note générale :
Saudi Medical Journal, 2003, 24, (Suppl. 2), S81-S86
Note de contenu :
tabl.
Résumé :
ENGLISH :
Objective: The aim of the study is to determine the seroprevalence of hepatitis C virus (HCV) in blood donors, children, pregnant women, hemodialysis patients and drug addicts in Saudi Arabia. Methods: Using third generation enzyme immunoassay kits, we have screened Saudi cohorts of all ages and sexes, namely infants, pre-school, school children, young adults and adults (blood donors and antenatals) for antibodies to HCV. We have also reviewed HCV seroprevalence data among high risk groups from 1998 to 2002. Results: An overall 1.1% (6313 out of 557813) seroprevalence rate was determined among Saudi blood donors; 0.1% (5 out of 3854) in Saudi children; and 0.7% (22 out of 3127) among pregnant women. Hemodialysis patients remain at highest risk of infection at 55.7% whereas intravenous drug addicts have 14% exposure rate. Conclusion: We conclude that the present public health schemes have been effective in reducing hepatitis C infection in the general community in the Kingdom of Saudi Arabia but the infection among high risk groups remain a major problem that needs to be actively addressed. (Review' s abstract)
Affiliation :
King Faisal Hospital & Research Centre
Arabie Saoudite. Saudi Arabia.
Arabie Saoudite. Saudi Arabia.
Cote :
A01592